Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BOLT Bolt Biotherapeutics	$5.53 -3.7%	$6.15	$5.20 ▼ $15.60	$10.62M	0.89	11,898 shs	21,711 shs
CZX Canada Zinc Metals	C$0.31 +∞	C$0.31	C$0.22 ▼ C$0.39	C$51.69M	N/A	238,645 shs	118,500 shs
FCR First Capital Realty		C$0.00	C$18.60 ▼ C$22.79	N/A	N/A	468,009 shs	3.04 million shs
FND Floor & Decor	$78.64 -1.7%	$76.95	$66.01 ▼ $124.68	$8.46B	1.7	1.82 million shs	1.30 million shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BOLT Bolt Biotherapeutics	0.00%	-9.18%	+1.77%	-18.00%	-61.20%
CZX Canada Zinc Metals	0.00%	0.00%	0.00%	0.00%	0.00%
FCR First Capital Realty	0.00%	0.00%	0.00%	0.00%	0.00%
FND Floor & Decor	+1.88%	-6.19%	+9.71%	+14.16%	-14.90%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BOLT Bolt Biotherapeutics	2.7801 of 5 stars	3.2	2.0	0.0	0.0	3.3	1.7	1.3
CZX Canada Zinc Metals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCR First Capital Realty	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FND Floor & Decor	3.5637 of 5 stars	3.1	2.0	0.0	1.4	2.8	0.0	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BOLT Bolt Biotherapeutics	2.33	Hold	$50.00	804.16% Upside
CZX Canada Zinc Metals	0.00	N/A	N/A	N/A
FCR First Capital Realty	4.00	Strong Buy	N/A	N/A
FND Floor & Decor	2.19	Hold	$91.19	15.96% Upside

Current Analyst Ratings Breakdown

Latest FND, BOLT, CZX, and FCR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/24/2025	FND Floor & Decor	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	In-Line ➝ In-Line	$85.00 ➝ $80.00
5/20/2025	BOLT Bolt Biotherapeutics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$80.00
5/13/2025	BOLT Bolt Biotherapeutics	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$25.00 ➝ $20.00
5/6/2025	FND Floor & Decor	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$95.00 ➝ $75.00
5/2/2025	FND Floor & Decor	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$91.00 ➝ $78.00
5/2/2025	FND Floor & Decor	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$80.00 ➝ $75.00
5/2/2025	FND Floor & Decor	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sell ➝ Sell	$81.00 ➝ $70.00
5/2/2025	FND Floor & Decor	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$100.00 ➝ $80.00
5/2/2025	FND Floor & Decor	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$115.00 ➝ $100.00
5/2/2025	FND Floor & Decor	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$90.00 ➝ $80.00
5/2/2025	FND Floor & Decor	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$110.00 ➝ $92.00

(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BOLT Bolt Biotherapeutics	$7.69M	1.38	N/A	N/A	$29.89 per share	0.19
CZX Canada Zinc Metals	N/A	N/A	N/A	N/A	N/A	N/A
FCR First Capital Realty	N/A	N/A	N/A	N/A	N/A	N/A
FND Floor & Decor	$4.46B	1.90	$4.04 per share	19.47	$20.21 per share	3.89

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BOLT Bolt Biotherapeutics	-$63.12M	-$33.40	N/A	N/A	N/A	N/A	-94.51%	-59.07%	8/12/2025 (Estimated)
CZX Canada Zinc Metals	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
FCR First Capital Realty	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
FND Floor & Decor	$205.87M	$1.89	41.61	30.13	2.44	4.53%	9.32%	3.95%	7/31/2025 (Confirmed)

Latest FND, BOLT, CZX, and FCR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	Q2 2025	BOLT Bolt Biotherapeutics	-$6.40	N/A	N/A	N/A	$0.82 million	N/A
7/31/2025	Q2 2025	FND Floor & Decor	$0.57	N/A	N/A	N/A	$1.21 billion	N/A
5/12/2025	Q1 2025	BOLT Bolt Biotherapeutics	-$6.80	-$5.80	+$1.00	-$0.29	$0.77 million	$1.22 million
5/1/2025	Q1 2025	FND Floor & Decor	$0.45	$0.45	N/A	$0.45	$1.16 billion	$1.16 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BOLT Bolt Biotherapeutics	N/A	N/A	N/A	N/A	N/A
CZX Canada Zinc Metals	N/A	N/A	N/A	N/A	N/A
FCR First Capital Realty	N/A	N/A	N/A	N/A	N/A
FND Floor & Decor	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BOLT Bolt Biotherapeutics	0.48	3.13	3.13
CZX Canada Zinc Metals	N/A	N/A	N/A
FCR First Capital Realty	N/A	N/A	N/A
FND Floor & Decor	0.09	1.22	0.27

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BOLT Bolt Biotherapeutics	86.70%
CZX Canada Zinc Metals	N/A
FCR First Capital Realty	N/A
FND Floor & Decor	N/A

Insider Ownership

Company	Insider Ownership
BOLT Bolt Biotherapeutics	6.10%
CZX Canada Zinc Metals	N/A
FCR First Capital Realty	N/A
FND Floor & Decor	2.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BOLT Bolt Biotherapeutics	90	1.92 million	1.80 million	Not Optionable
CZX Canada Zinc Metals	147,000	166.73 million	N/A	Not Optionable
FCR First Capital Realty	N/A	N/A	N/A	Not Optionable
FND Floor & Decor	13,690	107.61 million	105.35 million	Optionable

FND, BOLT, CZX, and FCR Headlines

Recent News About These Companies

Massachusetts Financial Services Co. MA Raises Stock Position in Floor & Decor Holdings, Inc. (NYSE:FND)

July 18 at 5:36 AM | marketbeat.com

Floor & Decor: Building Tomorrow's Strength In Today's Downturn

July 17 at 12:17 PM | seekingalpha.com

Analysts Set Floor & Decor Holdings, Inc. (NYSE:FND) Price Target at $91.19

July 17 at 3:21 AM | americanbankingnews.com

Floor & Decor: Expensive High Quality

July 16 at 12:43 PM | seekingalpha.com

Envestnet Asset Management Inc. Has $22.26 Million Stock Position in Floor & Decor Holdings, Inc. (NYSE:FND)

July 16 at 3:43 AM | marketbeat.com

Strata Wealth Advisors LLC Sells 8,938 Shares of Floor & Decor Holdings, Inc. (NYSE:FND)

July 14, 2025 | marketbeat.com

TimesSquare Capital Management LLC Grows Stock Position in Floor & Decor Holdings, Inc. (NYSE:FND)

July 14, 2025 | marketbeat.com

Floor & Decor Holdings, Inc. (NYSE:FND) Given Average Recommendation of "Hold" by Analysts

July 14, 2025 | marketbeat.com

Bank of New York Mellon Corp Reduces Stock Position in Floor & Decor Holdings, Inc. (NYSE:FND)

July 13, 2025 | marketbeat.com

Teacher Retirement System of Texas Increases Stock Holdings in Floor & Decor Holdings, Inc. (NYSE:FND)

July 11, 2025 | marketbeat.com

Floor & Decor Holdings, Inc. Announces Second Quarter Fiscal 2025 Earnings Conference Call

July 10, 2025 | businesswire.com

Reflecting On Home Furnishing and Improvement Retail Stocks’ Q1 Earnings: Floor And Decor (NYSE:FND)

July 10, 2025 | msn.com

Bridges Investment Management Inc. Grows Stake in Floor & Decor Holdings, Inc. (NYSE:FND)

July 9, 2025 | marketbeat.com

Investors Purchase Large Volume of Put Options on Floor & Decor (NYSE:FND)

July 8, 2025 | marketbeat.com

Fisher Funds Management LTD Raises Stake in Floor & Decor Holdings, Inc. (NYSE:FND)

July 4, 2025 | marketbeat.com

Principal Financial Group Inc. Purchases 1,558,409 Shares of Floor & Decor Holdings, Inc. (NYSE:FND)

July 4, 2025 | marketbeat.com

Floor & Decor Holdings, Inc. (NYSE:FND) is Worldly Partners Management LLC's Largest Position

July 3, 2025 | marketbeat.com

Allspring Global Investments Holdings LLC Acquires Shares of 313,786 Floor & Decor Holdings, Inc. (NYSE:FND)

July 2, 2025 | marketbeat.com

Floor & Decor (NYSE:FND) Trading Up 7.5% - Time to Buy?

July 1, 2025 | marketbeat.com

FND Floor & Decor Holdings, Inc. - Seeking Alpha

July 1, 2025 | seekingalpha.com

Floor & Decor (NYSE:FND) Cut to Sell at Wall Street Zen

June 27, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

FND, BOLT, CZX, and FCR Company Descriptions

Bolt Biotherapeutics NASDAQ:BOLT

$5.53 -0.21 (-3.66%)

Closing price 03:59 PM Eastern

Extended Trading

$5.56 +0.04 (+0.63%)

As of 06:52 PM Eastern

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals CVE:CZX

C$0.31 +0.31 (+∞)

As of 05/4/2018

Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.

First Capital Realty TSE:FCR

Floor & Decor NYSE:FND

$78.64 -1.39 (-1.74%)

Closing price 03:59 PM Eastern

Extended Trading

$78.62 -0.02 (-0.03%)

As of 06:30 PM Eastern

Floor & Decor Holdings, Inc. engages in the retail of hard surface flooring and related accessories. It provides wood, stone, and flooring products. Its products include vinyl, laminate, and tiles with materials installation for living rooms, kitchen, bathrooms, and walls. The company was founded by George Vincent West in 2000 and is headquartered in Atlanta, GA.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time